Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Non-hypovolemic Non-acute Hyponatremia
NCT01507727Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Jan 2012
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in hyponatremia, sponsored by Hengrui. Status: unknown.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT01507727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01507727.